| Name | Title | Contact Details |
|---|
Evidation Health is a technology and services company that helps individuals and the world`s most innovative healthcare companies understand and influence the everyday behaviors that create better health outcomes. Evidation pairs a first of its kind discovery engine designed for better, faster, and more efficient studies with a delivery platform that connects individuals and the healthcare industry, including life sciences organizations, providers, payers, and digital health companies. The company`s technology is designed to be entirely privacy-safe and individually-permissioned. Evidation Health`s mission is to enable and empower everyone to participate in better health outcomes. The company is headquartered in San Mateo, CA, with additional offices in Santa Barbara, CA.
DDB Corbett is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Glen Oaks is a New London, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cardiostaff Corporation is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities surrounding diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, kidney function, residual insulin, and presence of steroids.